Drug interactions
Bortezomib + Lemborexant
Severity: Minor
Bortezomib and Lemborexant: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Bortezomib is a weak CYP3A4 inhibitor in vitro and could slightly raise lemborexant exposure. This could increase next-day somnolence. The effect is likely small.
What this interaction means in plain words
Bortezomib and Lemborexant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Bortezomib belongs to Oncology; Lemborexant belongs to Central Nervous System.
Why it happens
Bortezomib may weakly inhibit CYP3A4, reducing lemborexant clearance.
What to do
Monitor for excess sedation and next-day impairment, and use the lower lemborexant dose if needed.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bortezomib and Lemborexant, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Bortezomib
- Apalutamide + Bortezomib Major
- Bortezomib + Carbamazepine Major
- Bortezomib + Etrasimod Major
- Bortezomib + Fosphenytoin Major
- Bortezomib + Idelalisib Major
- Bortezomib + Lonafarnib Major
Other interactions of Lemborexant
Frequently asked questions
Can I take Bortezomib with Lemborexant?
MediHelp rates the interaction as minor. Bortezomib and Lemborexant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Bortezomib is a weak CYP3A4 inhibitor in vitro and could slightly raise lemborexant exposure. This could increase next-day somnolence. The effect is likely small.
How serious is the interaction between Bortezomib and Lemborexant?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for excess sedation and next-day impairment, and use the lower lemborexant dose if needed.
What other medicines interact with Bortezomib?
MediHelp also lists interactions of Bortezomib with, for example, Apalutamide, Carbamazepine, Etrasimod. The full list is on the Bortezomib page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
